By
Pat Hagan
16:40 EST, 15 July 2012
|
21:16 EST, 15 July 2012
A diabetes drug costing as little as 2p a tablet could offer a major breakthrough in the treatment of prostate cancer.
Research has shown that the medicine, called metformin, causes tumours to shrink by slowing the rate at which cancerous cells grow.
If the results are confirmed in bigger trials, it raises the possibility that men could be given the cheap, readily available drug as soon as they are diagnosed.

Hope for the future: Diabetes drug metformin, which
costs as little as 2p a tablet, could offer a major breakthrough in the
treatment of prostate cancer
Nearly 40,000 cases of prostate
cancer are diagnosed every year in the UK and 10,000 men die from it –
the equivalent of more than one an hour.
The risks of developing a tumour increase with age, and there is a strong genetic element to the disease.
Metformin is widely used on the NHS to treat patients with type 2 diabetes.
But
recent studies highlighting the drug’s effects against a variety of
tumours have generated considerable excitement among cancer researchers
looking for powerful new treatments.
Last year, scientists discovered it could slash the risk of ovarian cancer by around 40 per cent.
And
Cancer Research UK is currently funding a major five-year study,
involving early 5,000 British women with breast cancer, to see if the
drug will stop the disease returning and boost survival rates.
Other
research teams around the world are investigating metformin’s powers
against skin, lung and pancreatic cancer, with promising early results.
In
the latest breakthrough, doctors at the Princess Margaret Hospital in
Toronto, Canada, tested the drug on 22 men after they noticed that it
stunted prostate cancer cell growth in laboratory experiments.
All of the men had been diagnosed with tumours and were due to undergo surgery to have their prostates removed.
For
six weeks before their operation, each one took 500mg of metformin
three times a day, during which time researchers measured the rate at
which the tumour cells multiplied.
The
results, presented at the recent American Association for Cancer
Research annual meeting in Chicago, showed malignant cells grew at a
significantly slower rate once the men were put on the drug, suggesting
metformin might be able to keep tumours under control.
The
findings support a 2009 study which found that men taking metformin
every day to control their diabetes were up to 44 per cent less likely
to develop prostate cancer.
Dr
Anthony Joshua, a cancer specialist who carried out the latest study,
said: ‘We compared what the prostate cancer looked like when it was
first diagnosed to what it looked like when it was removed.
‘And although these are preliminary results, it appeared to reduce the growth rate of prostate cancer in a proportion of men.’
Metformin
works by reducing the amount of glucose produced by the liver and
helping cells mop up sugar that is circulating in the bloodstream,
preventing damage from excessive blood sugar levels.
At about £30 per patient per year – or just 6p to 8p a day – it could be a highly cost-effective way to tackle prostate tumours.
Eleanor
Barrie, Cancer Research UK’s senior science information officer, said:
‘Larger trials will tell us more in the next few years.’
…AND SPINACH ‘WILL HELP PROTECT YOUR LIVER’
Scientists have revealed a new secret weapon in the battle against liver cancer: spinach.
Munching on Popeye’s favourite snack can slash the likelihood of developing the disease, which is the third most common cause of cancer deaths in the world.
Boffins claim high levels of Vitamin E in the leafy green vegetable help stave off the illness, along with other foods including nuts, sunflower seeds, avocados and dried apricots.

Eat yer greens: Popeye’s favourite food can protect your liver from cancer
The vitamin has long been associated with a reduced risk of cancer although results from studies have proved inconsistent.
Now new research published in the Journal of the National Cancer Institute claims a high consumption of Vitamin E through diet or supplements DOES affect risk levels.
Wei Zhang of the Shanghai Cancer Institute worked with colleagues to analyse results of the dietary habits of 132,837 people in Shanghai.
They found that those who had a high intake of the vitamin had a lower risk of developing the disease when compared to those who had a low intake.
‘In summary, in these two population-based cohort studies of 132,837 women and men, we found that high intake of vitamin E either from diet or supplements was related to lower risk of liver cancer in middle-aged or older people from China,’ the authors of the study wrote.
‘If confirmed, these findings could open a new venue for prevention of liver cancer, the third most common cause of death worldwide.’
In the study, researchers analysed data from 132,837 people in China who were enrolled in the Shanghai Women’s Health Study and the Shanghai Men’s Health Study.
The participants had enrolled in their programmes – jointly conducted by the Shanghai Cancer Institute and Vanderbilt University – between 1997 and 2006.
They completed questionnaires and underwent in-person interviews so researchers could meticulously detail their dietary habits.
Researchers compared the liver cancer risk of participants who had a high intake of Vitamin E with those who did not.
Of the patients, 118 woman and 149 men were diagnosed with liver cancer between two and 11 years after starting the study.
Taking vitamin E in supplements and also dietary form were both associated with a lower risk of the cancer – and was consistent in those who had a family history of liver cancer.
-
How different can one man look? Hilarious portraits of…
-
French demand Crown Jewels from the Queen to compensate for…
-
Olympic security farce: Now MI5 sacks systems experts after…
-
Edwardian street style: Astonishing amateur images which…
-
Who are they? Hunt for mystery military man and new fiancée…
-
Women overtake men in IQ tests for the first time in 100…
-
Why the man behind £500m lingerie empire jumped off the…
-
City of the Century that became a ghost town: Tragic…
-
Competitors told Olympic Park isn’t ready just TWO WEEKS…
-
Did Eva’s body lay undiscovered for FOUR weeks? Loyal…
-
Search for missing sisters ends in tragedy as their bodies…
-
Hilarious chalkboard signs offer bacon, booze and breakfasts…
Share this article:
Here’s what other readers have said. Why not add your thoughts,
or debate this issue live on our message boards.
The comments below have not been moderated.
-
Newest -
Oldest -
Best rated -
Worst rated
I know it’s completely irrelevant to the topic of this article but….I’ve never seen five o’clock shadow on a tummy before.
Report abuse
Doubly good for those who suffer from diabetes and prostate trouble.
Report abuse
I recall having to take a tablet and it was discovered that a beneficial side effect was that it helped some bald men to start growing new hair. The phamaceutical company then decided to introduce another version under the name of ‘regain’ with different packaging and promptly charged more than 5 times the price for it! They did no research at all for it however we all know that often the companies state that researching a product cost a lot of money!!
Report abuse
cannabis oil works well and with no side affects…..goggle….run from the cure
– “John#32, trat, 16/7/2012 03:41==== funny you are getting red arrows for telling the truth is it not?
Report abuse
Will this be prescribed in the same way that Statins are ?
One a day for everybody as a health ‘precaution’ and not cure ?
Report abuse
I have beentaking 500mg of metformin three times a day for years but still my prostate cancer is returning. Think again the side effects of Metformin can be pretyy devastating.
Report abuse
What is all this blather about? Metformin is and has been the standard treatment in the UK for type 2 diabetes for years. By the way DM in your picture you show capsules not tablets, do try to get some things correct.
Report abuse
My husband has been taking Metformin for years, and still developed prostate cancer!
Report abuse
Can’t get approved for use in the UK fast enough.
Report abuse
ahhh, the pharmaceutical companies wont like this one!! – not sure who i am half the time!, Or Where!, 16/07/2012 00:30. . I work for pharmaceutical companies and you couldn’t be more wrong. We would love to see an end to disease – wouldn’t it be great if we could all live forever. If that happened, we would happily give up our jobs and use our abilities to do other things.
Report abuse
The views expressed in the contents above are those of our users and do not necessarily reflect the views of MailOnline.
